Zafer Parlak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zafer Parlak has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Emine Türkoğlu
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Tokat Gaziosmanpaşa University, 60030 Tokat, Türkiye
1 shared publication - Sener Barut
Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa University Medical Faculty, Tokat, Türkiye
1 shared publication - Zafer Özmen
GAZİOSMANPAŞA ÜNİVERSİTESİ, TIP FAKÜLTESİ
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (6) , 1984-1990
Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis
Background/aim: Currently, hepatitis C virus (HCV) infection can be cured by direct-acting antivirals (DAAs). In this study, we aimed to find the rate of viremia among patients with a positive anti-HCV test and the rate of antiviral treatment given to viremic patients. We also aimed to reach patients with anti-HCV positivity but not tested for HCV-RNA, and patients, who were diagnosed with HCV-RNA positivity but received no treatment. Materials and methods: In this study, individuals tested for anti-HCV in Tokat Gaziosmanpaşa University Research and Application Hospital in the period between January 2010 and January 2020 were reviewed retrospectively. Anti-HCV positive patients, who were not tested for HCV-RNA, and HCV-RNA positive patients, who did not receive treatment, were called for a follow-up visit in the outpatient clinic. Results: The prevalences of anti-HCV positivity and viremia among patients were 2.24% and 0.67%, respectively. A HCV-RNA test was ordered in 71.7% of the anti-HCV positive patients. Antiviral treatment was not given to 44.4% of the viremic patients. Of the patients, who were called for a follow-up visit in the outpatient clinic, 3.9% attended the visit. Of these patients, 0.8% were HCV-RNA positive and 0.7% received treatment. Conclusion: Although the rate of HCV-RNA testing was relatively high in patients with anti-HCV positivity, almost half of them did not receive treatment. We could reach only one-third of the patients, who were called for a follow-up visit, and only a few patients received treatment. Individuals with anti-HCV positivity should be referred to a specialist without delay and HCV-RNA testing should be performed immediately to achieve HCV elimination targets. The likelihood of difficulties in reaching patients later should be considered.
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (6) , 1984-1990
Open AccessAssessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis
Background/aim: Currently, hepatitis C virus (HCV) infection can be cured by direct-acting antivirals (DAAs). In this study, we aimed to find the rate of viremia among patients with a positive anti-HCV test and the rate of antiviral treatment given to viremic patients. We also aimed to reach patients with anti-HCV positivity but not tested for HCV-RNA, and patients, who were diagnosed with HCV-RNA positivity but received no treatment. Materials and methods: In this study, individuals tested for anti-HCV in Tokat Gaziosmanpaşa University Research and Application Hospital in the period between January 2010 and January 2020 were reviewed retrospectively. Anti-HCV positive patients, who were not tested for HCV-RNA, and HCV-RNA positive patients, who did not receive treatment, were called for a follow-up visit in the outpatient clinic. Results: The prevalences of anti-HCV positivity and viremia among patients were 2.24% and 0.67%, respectively. A HCV-RNA test was ordered in 71.7% of the anti-HCV positive patients. Antiviral treatment was not given to 44.4% of the viremic patients. Of the patients, who were called for a follow-up visit in the outpatient clinic, 3.9% attended the visit. Of these patients, 0.8% were HCV-RNA positive and 0.7% received treatment. Conclusion: Although the rate of HCV-RNA testing was relatively high in patients with anti-HCV positivity, almost half of them did not receive treatment. We could reach only one-third of the patients, who were called for a follow-up visit, and only a few patients received treatment. Individuals with anti-HCV positivity should be referred to a specialist without delay and HCV-RNA testing should be performed immediately to achieve HCV elimination targets. The likelihood of difficulties in reaching patients later should be considered.
- 25 June 2020
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 10 (2) , 261-265
Abdominal US Findings of Crimean-Congo Hemorrhagic Fever
Introduction: Crimean-Congo hemorrhagic fever (CCHF) is one of the deadly diseases, clinically causing viral hemorrhagic fever outbreaks. It is especially transmitted through tick bite and body secretions and accepted as an indigenous disease in certain regions in the world and in our country. Many of the organs, especially the lungs, are affected by this disease. However, current studies are not sufficiently relate the disease and abdominal organ involvement. Therefore, we aim to discuss the ultrasonography (US) findings of the CCHF disease in the context of the literature. Material and Method: The retrospective analysis of the hospital records of 283 patients, who were serologically diagnosed as CCHF between 2012-2016 was performed. Abdominal ultrasonography examination revealed that, 20 of those patients had findings in the womb. US findings of these 20 patients were analyzed. Results Nine patients (45%) were male, and 11 patients (55%) were female. The most common findings of abdominal US examinations were; the hepatomegalia and the intra-abdominal free fluid. Gallbladder wall thickening and splenomegalia were also commonly found in these patients. Periportal hyperechogenicity, intramuscular hemorrhage, colon wall thickening, sludge in gallbladder, renal hyperechogenicity, renal ectasia and ureter dilatation were rarely observed. Conclusion Our study is among the exceptional studies on the analysis of abdominal US findings of CCHF. The most commonly observed findings in our patients were the hepatomegalia and the intra-abdominal free fluid. Intra-abdominal findings of the disease were extremely variable. This study will shed light to the future comprehensive studies.
- 25 June 2020
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 10 (2) , 261-265
Abdominal US Findings of Crimean-Congo Hemorrhagic Fever
Introduction: Crimean-Congo hemorrhagic fever (CCHF) is one of the deadly diseases, clinically causing viral hemorrhagic fever outbreaks. It is especially transmitted through tick bite and body secretions and accepted as an indigenous disease in certain regions in the world and in our country. Many of the organs, especially the lungs, are affected by this disease. However, current studies are not sufficiently relate the disease and abdominal organ involvement. Therefore, we aim to discuss the ultrasonography (US) findings of the CCHF disease in the context of the literature. Material and Method: The retrospective analysis of the hospital records of 283 patients, who were serologically diagnosed as CCHF between 2012-2016 was performed. Abdominal ultrasonography examination revealed that, 20 of those patients had findings in the womb. US findings of these 20 patients were analyzed. Results Nine patients (45%) were male, and 11 patients (55%) were female. The most common findings of abdominal US examinations were; the hepatomegalia and the intra-abdominal free fluid. Gallbladder wall thickening and splenomegalia were also commonly found in these patients. Periportal hyperechogenicity, intramuscular hemorrhage, colon wall thickening, sludge in gallbladder, renal hyperechogenicity, renal ectasia and ureter dilatation were rarely observed. Conclusion Our study is among the exceptional studies on the analysis of abdominal US findings of CCHF. The most commonly observed findings in our patients were the hepatomegalia and the intra-abdominal free fluid. Intra-abdominal findings of the disease were extremely variable. This study will shed light to the future comprehensive studies.